At a Glance – Zika in the U.S. (updated 3/8/17*)
Travel-associated Zika virus disease cases reported: 4,813
Locally acquired vector-borne cases reported: 221
Laboratory acquired cases reported: 1
Pregnant Women with Any Lab Evidence of Zika Virus Infection: 1,534
Liveborn infants with birth defects: 47
Pregnancy losses with birth defects: 5
Of the 5,109 cases reported, 45 were sexually transmitted and 13 had Guillain-Barré syndrome.
Travel-associated cases reported: 147
Locally acquired cases reported: 37,952
Pregnant Women with Any Lab Evidence of Zika Virus Infection: 3,225
Of the 38,099 cases reported, 51 had Guillain-Barré syndrome.
*Visit CDC.gov for the most up to date information.
New from ASTHO: Top Questions on Zika: Simple Answers
Zika virus is a mosquito-borne flavivirus transmitted to humans primarily by the Aedes aegypti mosquitoes, the same mosquitoes that transmit dengue, yellow fever, and chikungunya viruses. CDC estimates that 80 percent of Zika cases are asymptomatic. Symptomatic cases usually result in mild illness and symptoms such as acute onset of fever, rash, joint pain, and conjunctivitis. Some evidence suggests severe outcomes such as Guillian-Barre syndrome and microcephaly in infants via maternal-fetal transmission of Zika virus. There is currently no vaccine to prevent or medicine to treat Zika virus. For more information on Zika virus in the United States see CDC's Zika Virus web page: www.cdc.gov/Zika.
ASTHO staff have compiled the following links to selected resources and background materials that were created by state and territorial health departments and national and international sources for use by state health agency leaders. We'll add to these materials periodically.
ASTHO Congressional Briefing, March 8, 2017
In collaboration with CSTE, APHL, and AMCHP, ASTHO hosted a congressional briefing this week on Capitol Hill, convening nearly two dozen leading state and territorial health officials to showcase public health in action, educate lawmakers on the importance of public health and the impact of proposed cuts to the Prevention and Public Health Fund. Topics discussed during the briefing included state and territorial responses to Zika, the opioid epidemic, as well as the nation’s ever-changing environmental health challenges. Brenda Fitzgerald, MD, commissioner of the Georgia Department of Public Health and ASTHO president-elect, as well as Celeste Philip, MD, surgeon general and secretary of the Florida Department of Health, began the briefing with a discussion on the Zika response in Georgia and Florida respectively. Read more »
CDC Hosts Webinar on Sustaining the Zika Response in 2017
The CDC State Coordination Task Force will host one-hour webinars highlighting Zika lessons learned, updates to CDC Zika guidance, and functional task force recommendations for both CDC and jurisdictional actions for 2017. The schedule for the webinars in the series is below:
- Communications – March 22
- Epidemiology – March 23
- Vector Issues – March 28
- Public and Private Partnerships – March 29
- Pregnancy and Birth Defects – March 29
- Blood Safety – March 30
Global Challenges Roundtable Series: Facing the Zika Crisis and Other Emerging Threats
Hosted by the Howard Baker Forum, Purdue University Discovery Park, Purdue Institute of Inflammation-Immunology-Infectious Disease and Gallup. The roundtable is scheduled for Tuesday, March 14 from 9 a.m.-12 p.m. ET at Gallup World Headquarters in Washington, DC. Please RSVP here.
TFAH Congressional Briefing on the State of America’s Readiness for Infectious Disease Outbreaks, Disasters, and Bioterrorism
In December, Trust for America's Health released a report, Ready or Not? Protecting the Public from Diseases, Disasters, and Bioterrorism, which stated that the nation is often caught off guard when a new threat arises, such as Zika or the Ebola outbreak or a bioterrorist threat, which then requires diverting attention and resources away from other priorities. This briefing aims to inform policymakers and partners on steps the nation can take to prevent and respond to various threats. Invited speakers include:
- Dr. S. Atyia Martin CEM, Chief Resilience Officer, City of Boston
- John J. Dreyzehner, MD, MPH, FACOEM, Commissioner, Tennessee Department of Health
- Paul Kuehnert, DNP, RN, FAAN, Assistant Vice President - Program, Robert Wood Johnson Foundation
- John Auerbach (moderator), President and CEO, Trust for America’s Health
This briefing will take place on Thursday, March 23 at the Capitol Visitor Center, room SVC 201-00 in Washington, DC. To RSVP or for more information, please click here.
New Jersey: NJDOH and NJ American Academy of Pediatrics Co-Sponsors Conference "From ALD to Zika: Newborn Screening and Surveillance in New Jersey"
Date: April 25, 2017
Time: 8:30 a.m. – 3:30 p.m.
Location: National Conference Center, 399 Monmouth Street, East Windsor, NJ
Registration Fee: $25
This information page was developed by ASTHO to help state and territorial health officials and state health agencies stay abreast of a developing public health concern in the form of background information, pertinent materials, and ongoing updates. ASTHO staff will continue to monitor this situation. Health agencies may contact email@example.com with questions regarding this topic.